A drug for Type 2 diabetes made by Takeda Pharmaceutical taken in the morning prevented the disease from developing in nearly three-quarters of patients who were at risk, according to a new study in the New England Journal of Medicine.

The Food and Drug Administration is warning that long-term use of a class of drugs for gastroesophageal reflux disease may decrease levels of magnesium in the body and increase the risk of such side effects as seizures and heart rhythm problems, according to published reports.

The National Advertising Division of the Council of Better Business Bureaus on Tuesday ruled that Procter & Gamble provided reasonable support for claims that Prilosec OTC provides “superior acid control” over a competing product, Prevacid 24HR. However, the NAD recommended P&G discontinue a comparative claim made in a context that doesn’t reference acid control, the review board added.

Dr. Reddy's disclosed on Tuesday it will market a generic peptic ulcer treatment....

The Food and Drug Administration has approved a generic drug for HIV made by a...

The Food and Drug Administration said Friday it had begun a safety review of Takeda’s...

A joint advisory committee of the Food and Drug Administration has voted to recommend allowing...

The Food and Drug Administration has granted tentative approval to Perrigo’s generic version of a...

A generic version of a gastroesophageal reflux disease drug that dissolves in the mouth doesn’t...